Literature DB >> 19871694

PREPARATION FROM HUMAN RED CELLS OF A SUBSTANCE INHIBITING VIRUS HEMAGGLUTINATION.

P M Deburgh1, P C Yu, C Howe, M Bovarnick.   

Abstract

Methods have been described for the extraction and purification of an agent inhibiting the hemagglutination of red cells by influenza (PR8) and mumps viruses. Human red cells have served as the chief source of the inhibitor but the latter has also been found in human lung. The active extracts have been purified to the extent that 0.1 gamma of material suffices to inhibit one hemagglutinating dose of virus. Incomplete chemical characterization of the most highly purified fractions available indicates the presence of 2.6 per cent nitrogen, at least 50 per cent of polysaccharide, and no phosphorus. In the ultracentrifuge the purified preparation behaves as a polydisperse macromolecular substance. The active material can be obtained from red cell stroma in an ether- and chloroform-soluble form which, on further treatment, can be converted into chloroform-insoluble material. It is possible that the former represents more closely the virus receptor as it exists in the red cell. The purified inhibitor is inactivated on incubation with the virus at 37 degrees C. The nature of this effect is being investigated.

Entities:  

Keywords:  ERYTHROCYTE/substance inhibiting virus action; VIRUS/hemagglutination, inhibition

Mesh:

Substances:

Year:  1948        PMID: 19871694      PMCID: PMC2135763          DOI: 10.1084/jem.87.1.1

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  4 in total

1.  The protein component of the erythrocyte membrane or stroma.

Authors:  E Jorpes
Journal:  Biochem J       Date:  1932       Impact factor: 3.857

2.  Virus Hemagglutination.

Authors:  M Bovarnick; P M DE Burgh
Journal:  Science       Date:  1947-05-23       Impact factor: 47.728

3.  Properties of a Virus Inactivator From Yeast.

Authors:  W N Takahashi
Journal:  Science       Date:  1946-10-18       Impact factor: 47.728

4.  THE MODIFYING EFFECTS OF CERTAIN SUBSTANCES OF BACTERIAL ORIGIN ON THE COURSE OF INFECTION WITH PNEUMONIA VIRUS OF MICE (PVM).

Authors:  F L Horsfall; M McCarty
Journal:  J Exp Med       Date:  1947-05-31       Impact factor: 14.307

  4 in total
  7 in total

1.  [Nonspecific inhibitory factors against influenza viruses in the normal serum of guinea pigs].

Authors:  H LIPPELT; W WIRTH
Journal:  Arch Gesamte Virusforsch       Date:  1959

2.  [Not Available].

Authors:  W A COLLIER
Journal:  Antonie Van Leeuwenhoek       Date:  1949       Impact factor: 2.271

3.  INFLUENZA : I. THE HEMAGGLUTINATION AND INFECTIVITY TITRE CURVES OF PR8 INFLUENZA VIRUS CULTIVATED IN EMBRYONATED EGGS AT DIFFERENT TEMPERATURES.

Authors:  H T Blumenthal; D Greiff; H Pinkerton; R Dewitt
Journal:  J Exp Med       Date:  1950-02-28       Impact factor: 14.307

4.  Reactions between influenza virus and a component of allantoic fluid.

Authors:  P H HARDY; F L HORSFALL
Journal:  J Exp Med       Date:  1948-10-01       Impact factor: 14.307

5.  A mucoprotein derived from human urine which reacts with influenza, mumps, and Newcastle disease viruses.

Authors:  I TAMM; F L HORSFALL
Journal:  J Exp Med       Date:  1952-01       Impact factor: 14.307

6.  Studies on influenza virus receptor substance and receptor-substance analogues. II. Isolation and purification of a mucoprotein receptor substance from human erythrocyte stroma treated with pentane.

Authors:  J F McCREA
Journal:  Yale J Biol Med       Date:  1953-12

7.  The nature of the virus receptors of red cells; partial purification of the virus agglutination inhibitor in human plasma.

Authors:  G K HIRST
Journal:  J Exp Med       Date:  1949-02       Impact factor: 14.307

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.